Is There a Role for Surgery in the Treatment of Metastatic Urothelial Carcinoma?

Keyphrases

• Metastatic Urothelial Carcinoma 100%
• Bladder Cancer 57%
• Metastasectomy 57%
• Upper Tract Urothelial Carcinoma 42%
• Improved Survival 42%
• Cytoreductive Surgery 42%
• Urothelial Carcinoma 42%
• Radical Cystectomy 42%
• Metastasis 28%
• Survival Benefit 28%
• Metastasis Sites 28%
• Clinically Node-negative 28%
• Retrospective Review 14%
• Malignancy 14%
• Meta-analysis 14%
• 5-year Survival 14%
• Overall Survival 14%
• Chemotherapy 14%
• Medical Literature 14%
• Muscle-invasive Bladder Cancer 14%
• Patient Selection 14%
• MEDLINE 14%
• Metastatic Disease 14%
• Targeted Therapy 14%
• Newly Diagnosed Patients 14%
• Patient Characteristics 14%
• Transitional Cell Carcinoma 14%
• Distant Metastasis 14%
• Literature Search 14%
• Lymph Node Metastasis 14%
• Performance Status 14%
• Distant Site 14%
• Phase II Trial 14%
• Best Response 14%
• Literature Analysis 14%
• Response to Chemotherapy 14%
• Bladder Tumor 14%
• Literature Retrieval 14%
• Retrieval System 14%
• Cisplatin-based Chemotherapy 14%
• Nodal Involvement 14%
• Surgical Extirpation 14%
• Good Status 14%
• Prospective Phase II Study 14%
• Targeted Combination 14%
• Survival Impact 14%
• Cancer Bladder 14%
• Preprints 14%
• Bladder Metastasis 14%

Medicine and Dentistry

• Transitional Cell Carcinoma 100%
• Metastatic Carcinoma 45%
• Bladder Cancer 36%
• Metastasectomy 36%
• Cystectomy 27%
• Cancer 9%
• Immunotherapy 9%
• Meta-Analysis 9%
• Muscle Invasive Bladder Cancer 9%
• Patient Selection 9%
• Overall Survival 9%
• Targeted Therapy 9%
• Distant Metastasis 9%
• Patient Characteristics 9%
• Lymph Node Metastasis 9%
• Phase II Trials 9%
• Cisplatin 9%
• Dextromethorphan 9%
• Bladder Carcinoma 9%
• Bladder Tumor 9%
• Cytoreductive Surgery 9%
• Bladder Metastasis 9%
• Diseases 9%